Omeros | OMER - Cost Of Sales


Omeros reported $33.16M in Cost of Sales for its fiscal quarter ending in June of 2024.





Cost Of Sales Change Date
Adma Biologics USD 33.74M 16.65M Mar/2026
Alnylam Pharmaceuticals USD 298.45M 87.33M Jun/2026
BioMarin Pharmaceutical USD 276.29M 76.8M Jun/2026
Cytokinetics USD 5.59M 5.43M Jun/2026
Gilead Sciences USD 1000M 445M Jun/2026
Heron Therapeutics USD 11.12M 795K Dec/2025
Insmed USD 69.29M 19.79M Jun/2026
Knight Therapeutics CAD 82.22M 1.03M Dec/2025
MacroGenics USD 9.53M 585K Mar/2026
Omeros USD 33.16M 18.52M Jun/2024
Pacira USD 58.49M 7.75M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Rockwell Medical USD 21.28M 1.67M Jun/2024
Sangamo BioSciences 2.42M 1.11M Jun/2024
Sarepta Therapeutics USD 150.1M 40.64M Jun/2026
United Therapeutics USD 99.5M 33.9M Jun/2026
Vertex Pharmaceuticals USD 489.2M 96.4M Jun/2026